MedTrace Logo

Evaluate the Safety and Effectiveness of the Polymotion Hip Resurfacing (PHR) System Compared to Total Hip Arthroplasty

NCT06792539 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2026-05-01

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the safety and effectiveness of the Polymotion Hip Resurfacing (PHR) System compared to total hip arthroplasty, for adults who require hip resurfacing arthroplasty due to 1) non-inflammatory arthritis (degenerative joint disease) such as osteoarthritis, traumatic arthritis, or 2) mild dysplasia/developmental dislocation of the hip (DDH) up to Crowe Grade 1.

Conditions

  • Osteoarthritis of the Hip
  • Degenerative Joint Disease of Hip
  • Dysplasia; Hip

Interventions

DEVICE

Polymotion Hip Resurfacing (PHR) System

Surgical

Sponsors & Collaborators

  • JointMedica Inc.

    lead OTHER

Principal Investigators

  • Michael Mont, MD · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-22
Primary Completion
2028-04-30
Completion
2028-06-30
FDA Device
Yes

Countries

  • United States
  • Bermuda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06792539 on ClinicalTrials.gov